TSE:4553Pharmaceuticals
Towa Pharmaceutical (TSE:4553) Stock Faces Margin Questions After Profit Rebound
Towa Pharmaceutical stock has barely moved over the past month, yet the latest earnings landed like a reset button on sentiment. The headline is simple. After a recent quarter that produced a loss of ¥11,832m, Q1 2027 swung back to a profit of ¥5,531m with basic earnings per share at ¥112.36. For a company with a P/E of 23.6x and a thin 3% trailing net margin, that kind of earnings whiplash is exactly what stirs debate over whether today’s muted price action reflects caution or...